Clinical Trial Update: A Single-arm Trial of Prophylactic Tocilizumab for Acute GVHD Prevention After Haploidentical HSCT. [Phase 2]

View source ↗

Summary

A Phase 2 single-arm trial evaluating prophylactic tocilizumab to prevent acute graft-versus-host disease after haploidentical hematopoietic stem cell transplan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Leukemia

Drugs mentioned

• Tocilizumab (tocilizumab)

Snippet

Sponsor: Yi Luo | Conditions: Leukemia, Graft-versus-host-disease | Phase 2 | Status: UNKNOWN